In summary, the above findings indicated that TBK1, a key node of the cGAS–STING pathway, is implicated in metabolic disease-induced liver disease, but there is still no convincing evidence that the cGAS–STING pathway as a whole is associated with diabetes-related liver dysfunction, which requires further study. The gene discussed is CGAS; the disease is Other metabolic disease.